ResearcherDuke UniversityActive in the last 2 years
Austin M. Eckhoff
Matched on ORCID iD 0000-0002-6058-4971; OpenAlex author ID A5058696037. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2023: 3 papers · 2024: 1 paper · 2025: 1 paper
Papers 5
- A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. Co-author DOI 10.1007/s00262-025-04146-5↗
- Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-023-14751-2↗
- Revisiting the intrinsic mycobiome in pancreatic cancer. Co-author DOI 10.1038/s41586-023-06292-1↗
- Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Co-author DOI 10.1245/s10434-023-13318-5↗
- Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Co-author DOI 10.3389/fimmu.2023.1116034↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter J. Allen · 4 shared papers, 2023–2024 · strength 0.85
- Paper Revisiting the intrinsic mycobiome in pancreatic cancer. DOI 10.1038/s41586-023-06292-1↗
- Paper Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer. DOI 10.1245/s10434-023-14751-2↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Elishama N. Kanu · 3 shared papers, 2023–2025 · strength 0.62
- Paper Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer. DOI 10.1245/s10434-023-14751-2↗
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Daniel P. Nussbaum · 3 shared papers, 2023–2025 · strength 0.62
- Paper Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer. DOI 10.1245/s10434-023-14751-2↗
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Dan German Blazer · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Michael E. Lidsky · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Sabino Zani · 2 shared papers, 2023–2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemoth… DOI 10.1245/s10434-023-13318-5↗
- Ashley A. Fletcher · 1 shared paper, 2023 · strength 0.26
- Julia Button · 1 shared paper, 2025 · strength 0.20
- Tao Wang · 1 shared paper, 2025 · strength 0.20
- Erika J. Crosby · 1 shared paper, 2025 · strength 0.20
- Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.20
- Peter J. Allen · 1 shared paper, 2025 · strength 0.20
- Bruce A. Sullenger · 1 shared paper, 2023 · strength 0.16
- Smita K. Nair · 1 shared paper, 2023 · strength 0.16
- Ibtehaj A. Naqvi · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.